Max International Assigned Patent to Ribose-Cysteine (RiboCeine®), a Groundbreaking Health-Enhancing

Max International, a global supplier and wholesale distributor of energy- and health-enhancing products, has been assigned the U.S. patent for RiboCeine by its creator, Dr. Herbert Nagasawa. Salt Lake City, UT (PRWEB) August 05, 2014 Max International, a global supplier and wholesale distributor of energy- and health-enhancing products, has been assigned the U.S. patent for RiboCeine by its creator, Dr. Herbert Nagasawa. RiboCeine is a revolutionary compound shown to enhance the delivery of Glutathione and ATP levels in the cells. As a component in several of the company’s formulated supp
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations